News | July 13, 2022
Heathcare startup MedTel to raise around USD 10mn in Series A
MedTel aims to raise series A for rapid business expansion, product improvement & conducting relevant clinical validation studies.
MedTel aims to raise series A for rapid business expansion, product improvement & conducting relevant clinical validation studies.
The acquisition continues the growth and expansion course of the ALPLApharma business division established in 2019
The US FDA has determined that the inspection classification of the facility is Voluntary Action Indicated
Paliperidone Extended-Release Tablets (RLD Invega) had estimated annual sales of USD 152 million in the U.S
HIL has set up the Bti bio-larvicide manufacturing facility at its Rasayani Plant at Maharashtra with the financial assistance of GEF/UNIDO under the project
An interim analysis of this data shows no significant safety issues and a 91% seroconversion rate at Day 56.
The ground floor of the formulation development laboratory is focused on solid orals, the first floor on injections, and the second floor houses the analytical lab
TRIPS waiver for five years agreed in the recently concluded WTO will help countries manufacture COVID vaccines to deal with the pandemic
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD), Motrin Oral Suspension, 100 mg/5 mL, of McNeil Consumer Healthcare (McNeil)
JB, in its new avatar, emerges as the fastest growing pharmaceuticals company in India
Subscribe To Our Newsletter & Stay Updated
